Analysis of Clinical Outcomes in Patients Undergoing Magnetic Resonance-Guided Focused Ultrasound for Medication-Refractory Tremor
A legfontosabb adatok
- Ki végzi
- Sunnybrook Health Sciences Centre
- Hol
- Toronto (Kanada)A helyszín megnézése
- Azonosító
- Állapot
- Toboroz
- Résztvevők
- 240 fő, tervezett
- Kezdés
- 2025. okt.
- Várható befejezés
- 2032. szept.
- A vizsgálat típusa
- Megfigyeléses
- A regiszteradat frissítve
- 2025. október 8.
Ki vehet részt
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.
The trial is looking for adults with essential tremor that medicines have not controlled, who will have MRgFUS thalamotomy as standard care. Participants are followed for at least 3 years.
- Életkor
- 22 years or older
- Nem
- All sexes can join.
- A betegség stádiuma
- Essential tremor with moderate-to-severe hand tremor, confirmed by the MRgFUS neurology team. The surgical team must decide the person can have the procedure.
- Korábbi kezelés
- Tremor not controlled by at least two first-line tremor medications.
A részvétel fő kizáró okai
- Cannot have an MRI, for example because of implants or devices that are not MRI-safe
- Not fit for the procedure due to health problems, such as pregnancy, advanced kidney disease, unstable heart condition or severe high blood pressure
- Disease of the brain's blood vessels, brain tumour or lung disorders
- Taking blood thinners or drugs that raise bleeding risk within 2 weeks of the procedure
A regiszter feltételei, szó szerint
Mind a 8 feltétel megnézéseKevesebb
Ki vehet részt
- Aged 22 years or older
- Able and willing to give consent and to attend all visits
- Diagnosed with essential tremor that is refractory to at least two first-line tremor medications
- Confirmed to have moderate-to-severe hand tremor by the MRI guided Focused Ultrasound (MRgFUS) neurology team
- Deemed suitable surgical candidates (decision-to-treat) by the MRgFUS neurosurgical team
Ki nem vehet részt
- Patients with standard contraindications to MRI such as non-MRI compatible implants or devices
- Receiving anti-coagulants or drugs known to increase risk of hemorrhage within 2 weeks of MRgFUS procedure
- Patients deemed clinically unfit to undergo MRgFUS thalamotomy due to health status including (but not limited to) pregnancy, advanced kidney disease, unstable cardiac status, severe hypertension, cerebrovascular disease, brain tumour, pulmonary disorders
Helyszínek itt: Kanada
- Sunnybrook Health Sciences CentreToronto, KanadaContact: Nadia Scantlebury, PhDRésztvevőt keres
A vizsgálatról
Mit akar kideríteni a vizsgálat
The goal of this observational study is to evaluate the long-term efficacy and safety of MR-guided focused ultrasound (MRgFUS) thalamotomy in patients with medication-refractory essential tremor.
A teljes eredeti leírásKevesebb
The main questions it aims to answer are:
1. Does MRgFUS thalamotomy provide sustained reduction in tremor severity over 3 years? 2. What are the long-term neurological and quality-of-life outcomes associated with this procedure?
Participants will:
* Undergo MRgFUS thalamotomy as part of standard of care at Sunnybrook Health Sciences Centre. * Be followed prospectively for a minimum of 3 years with scheduled assessments including:
1. Clinical Rating Scale for Tremor (CRST) 2. Neurological exams and adverse event monitoring 3. Quality of Life in Essential Tremor (QUEST) questionnaire 4. Scale for the Assessment and Rating of Ataxia (SARA) 5. MRI imaging and neuropsychological testing
A vizsgálat csoportja
- Cohort 1: Magnetic Resonance-Guided Focused Ultrasound (MRgFUS) Thalamotomy
Patients with medication-refractory essential tremor who are scheduled to undergo MRgFUS thalamotomy at Sunnybrook Health Sciences Centre as part of standard of care. Eligible participants providing informed consent will be enrolled and followed prospectively for a minimum of 3 years to evaluate long-term efficacy and safety outcomes.
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- A Prospective, Long-term Analysis of Clinical Outcomes in Patients Undergoing Magnetic Resonance-Guided Focused Ultrasound for Medication-Refractory Tremor
- MI-összefoglaló
- A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
- A regiszteradat frissítve
- 2025. október 8.